Status:
COMPLETED
A New Treatment for Primary Dysmenorrhea
Lead Sponsor:
Halic University
Conditions:
Primary Dysmenorrhea (PD)
Eligibility:
FEMALE
18-30 years
Phase:
NA
Brief Summary
Primary dysmenorrhea (PD) is a chronic health condition that affects primarily young women and interferes with daily activities, causes loss of work productivity, and reduces quality of life. In this ...
Detailed Description
This controlled experimental study included 45 volunteers diagnosed with primary dysmenorrhea by a gynecologist. Participants were randomly assigned to three groups using the "Research Randomizer" web...
Eligibility Criteria
Inclusion
- Being a woman between the ages of 18 and 30
- Having a diagnosis of primary dysmenorrhea
- Not having given birth
- Having a regular menstrual cycle (28 ± 7 days)
Exclusion
- Having been diagnosed with rheumatic, gastrointestinal, psychiatric, neurological diseases, or other chronic pain syndromes
- Being on any anti-inflammatory, analgesic, or estrogen/progestin pill (OCP) treatment
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT07213336
Start Date
December 1 2022
End Date
May 1 2023
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Halic University
Istanbul, Turkey (Türkiye)